The ICEMVO annual flat fee is charged per market authorization holder to cover, inter alia, the annual costs of the operation and further development of the ICEMVS, costs inherited from the European Medicines Verification Organization and all necessary and legally compulsory activities of the ICEMVO. The level of the annual flat fee contribution is based on actual cost of running the ICEMVO short and long term.
The amount of the Annual Fee (operational cost of ICEMVO divided by number of contracted MAH’s) may fluctuate from time to time.
ICEMVO 2021 Annual Fee has been decided by ICEMVO Board of Directors. ICEMVO is happy to inform that there is an overall 10% reduction to the fees from the current year. This is made possible due to reduction in 2021 operational costs and higher number of MAH participating than originally foreseen.
ICEMVO 2021 Annual Fee:
- 4,410 € for MAH with IDM 2020 sales turnover above 80,000 €
- 1,350 € for MAH with IDM 2020 sales turnover below 80,000 €
- 405 € for MAH with IDM 2020 sales below 16,000 €.
For any further information please contact ICEMVO via email email@example.com.